IRCT20090117001556N106招募中3 期
5-hydroxytryptophan combination therapy with fluoxetine in the treatment of moderate to severe OCD: a double blind randomized trial with placebo control
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Age between 18-60 years old
- •Diagnosis of OCD based on DSM-5
- •inimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale
排除标准
- •Substance dependence
- •IQ less than 70
- •Any other mental disorder
- •Any serious cardiac, renal or hepatic disease
- •receiving psychotropic medications during the last 6 weeks
- •pregnancy or breast feeding
- •Rising liver transaminases to three times the upper limit of normal or higher
研究者
相似试验
尚未招募
2 期
Effect of supplementary oral 5-hydroxytryptophan on severity of depression in patients on chronic selective serotonin reuptake inhibitors; a clinical trialMajor depressionMental Health - DepressionAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12613001275752Daniel F Fouladi240
招募中
2 期
Dextromethorphan and Fluoxetine for the treatment of OCDObsessive-compulsive disorder.Obsessive-compulsive disorderIRCT20090117001556N158Tehran University of Medical Sciences50
进行中（未招募）
不适用
Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen) with Concomitant or Concomitant and Maintenance Administration of Cetuximab (Erbitux®), in First-Line Treatment of Metastatic Colorectal Cancer. - Nordic VIIPatient with metastatic colorectal cancer.EUCTR2005-000117-34-ISThe Nordic Colorectal Cancer Biomodulation Group550
进行中（未招募）
不适用
Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen) with Concomitant or Concomitant and Maintenance Administration of Cetuximab (Erbitux®), in First-Line Treatment of Metastatic Colorectal Cancer. - Nordic VIIPatient with metastatic colorectal cancer.EUCTR2005-000117-34-DKThe Nordic Colorectal Cancer Biomodulation Group550
进行中（未招募）
不适用
Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen) with Concomitant or Concomitant and Maintenance Administration of Cetuximab (Erbitux®), in First-Line Treatment of Metastatic Colorectal Cancer. - Nordic VIIPatient with metastatic colorectal cancer.EUCTR2005-000117-34-SEThe Nordic Colorectal Cancer Biomodulation Group550